Xena--thanks for posting article-"Alzheimer’s disease have started to show significant improvements, the principal investigator tells Australian Ageing Agenda."--had not seen this before--all very good--the drug works!!!!!
I understand that the initial allowance is for 21 participants.....but, We have to also understand that is because the requests were made only for those patients for the initial approval. Now that the approval is given, other physicians can follow the lead and request for the medicine/treatment. Anavex’s PR doesn’t say that it cannot give it to others. Let’s see how the things unfold in the coming days/weeks.
News 
Market Data 
Discover 
